Youngy Health Co., Ltd.

Symbol: 300247.SZ




Market price today

  • 164.5253

    P/E Ratio

  • 11.2371

    PEG Ratio

  • 2.39B

    MRK Cap

  • 0.00%

    DIV Yield

Youngy Health Co., Ltd. (300247-SZ) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Consumer Cyclical
Industry: Furnishings, Fixtures & Appliances
CEO:Ms. Fenling Xing
Full-time employees:483
Address:No. 34 Hehuan Road

Youngy Health Co., Ltd. engages in the manufacture and sale of sauna equipment in China. Its products include infrared sauna, traditional sauna, and foot sauna; and portable steam and infrared sauna products, as well as air purifiers. The company also offers carbon heating painting products, functional sofas and chairs, saunalux, and SUP and boat products. It exports its sauna products to approximately 70 countries. The company was founded in 1995 and is headquartered in Hefei, China.

General Outlook

In simple terms, Youngy Health Co., Ltd. has 804.04 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.293% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.063%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.027%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.011% return, is a testament to Youngy Health Co., Ltd.'s adeptness in optimizing resource deployment. Youngy Health Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.014%. Furthermore, the proficiency of Youngy Health Co., Ltd. in capital utilization is underscored by a remarkable 0.029% return on capital employed.

Stock Prices

Youngy Health Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $2.98, while its low point bottomed out at $2.86. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Youngy Health Co., Ltd.'s stock market.

Liquidity Ratios

Analyzing 300247.SZ liquidity ratios reveals its financial health of the firm. The current ratio of 722.40% gauges short-term asset coverage for liabilities. The quick ratio (489.34%) assesses immediate liquidity, while the cash ratio (102.94%) indicates cash reserves.

Current Ratio722.40%
Quick Ratio489.34%
Cash Ratio102.94%

Profitability Ratios

300247.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 6.42% underscores its earnings before tax deductions. The effective tax rate stands at 20.75%, revealing its tax efficiency. The net income per EBT, 42.50%, and the EBT per EBIT, 101.33%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 6.34%, we grasp its operational profitability.

Pretax Profit Margin6.42%
Effective Tax Rate20.75%
Net Income per EBT42.50%
EBT per EBIT101.33%
EBIT per Revenue6.34%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 7.22, it details the span from stock purchase to revenue. The 5 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 1245.30% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

Days of Sales Outstanding489
Days of Inventory Outstanding145
Operating Cycle174.56
Days of Payables Outstanding46
Cash Conversion Cycle128
Receivables Turnover12.45
Payables Turnover7.86
Inventory Turnover2.51
Fixed Asset Turnover2.21
Asset Turnover0.42

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.15, and free cash flow per share, 0.14, depict cash generation on a per-share basis. The cash per share value, 0.63, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.23, offers insight into cash flow relative to sales.

Operating Cash Flow per Share0.15
Free Cash Flow per Share0.14
Cash per Share0.63
Operating Cash Flow Sales Ratio0.23
Free Cash Flow to Operating Cash Flow Ratio0.93
Cash Flow Coverage Ratio5.88
Short Term Coverage Ratio10.02
Capital Expenditure Coverage Ratio15.03
Dividend Paid and Capex Coverage Ratio15.03

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 1.67%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.02, we discern the balance between debt and equity financing. The long-term debt to capitalization, 0.81%, and total debt to capitalization, 1.95%, ratios shed light on its capital structure.

Debt Ratio1.67%
Debt Equity Ratio0.02
Long Term Debt to Capitalization0.81%
Total Debt to Capitalization1.95%
Cash Flow to Debt Ratio5.88
Company Equity Multiplier1.19

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.58, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.16, reflects the portion of profit attributed to each share. The book value per share, 1.23, represents the net asset value distributed per share, while the tangible book value per share, 1.22, excludes intangible assets.

Revenue Per Share0.58
Net Income Per Share0.16
Book Value Per Share1.23
Tangible Book Value Per Share1.22
Shareholders Equity Per Share1.23
Interest Debt Per Share0.03
Capex Per Share-0.02

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -12.00%, indicates top-line expansion, while the gross profit growth, -12.52%, reveals profitability trends. EBIT growth, 258.20%, and operating income growth, 258.20%, offer insights into operational profitability progression. The net income growth, 421.87%, showcases bottom-line expansion, and the EPS growth, 433.33%, measures the growth in earnings per share.

Revenue Growth-12.00%
Gross Profit Growth-12.52%
EBIT Growth258.20%
Operating Income Growth258.20%
Net Income Growth421.87%
EPS Growth433.33%
EPS Diluted Growth433.33%
Weighted Average Shares Growth-2.15%
Weighted Average Shares Diluted Growth-2.15%
Operating Cash Flow Growth-370.08%
Free Cash Flow Growth-1115.54%
10-Year Revenue Growth per Share15.27%
5-Year Revenue Growth per Share-63.75%
3-Year Revenue Growth per Share-35.33%
10-Year Operating CF Growth per Share9.07%
5-Year Operating CF Growth per Share67.75%
3-Year Operating CF Growth per Share-129.77%
10-Year Net Income Growth per Share300.00%
5-Year Net Income Growth per Share143.27%
3-Year Net Income Growth per Share117.98%
10-Year Shareholders Equity Growth per Share6.78%
5-Year Shareholders Equity Growth per Share-59.64%
3-Year Shareholders Equity Growth per Share15.03%
10-Year Dividend per Share Growth per Share-100.00%
5-Year Dividend per Share Growth per Share-100.00%
3-Year Dividend per Share Growth per Share-99.96%
Receivables Growth-17.19%
Inventory Growth25.08%
Asset Growth16.11%
Book Value per Share Growth21.56%
Debt Growth-14.67%
R&D Expense Growth-18.86%
SGA Expenses Growth17.46%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 2,813,465,291.15, captures the company's total value, considering both debt and equity. Income quality, -0.22, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.02, gauges operational efficiency, while the research and development to revenue, 2.37%, highlights investment in innovation. The ratio of intangibles to total assets, 3.78%, indicates the value of non-physical assets, and capex to operating cash flow, 59.85%, measures reinvestment capability.

Enterprise Value2,813,465,291.15
Income Quality-0.22
Sales General and Administrative to Revenue0.02
Research and Development to Revenue2.37%
Intangibles to Total Assets3.78%
Capex to Operating Cash Flow59.85%
Capex to Revenue-3.78%
Capex to Depreciation-61.63%
Stock-Based Compensation to Revenue-1.45%
Graham Number2.09
Return on Tangible Assets11.06%
Graham Net Net0.48
Working Capital641,606,214
Tangible Asset Value983,871,863
Net Current Asset Value608,704,514
Average Receivables59,972,770.5
Average Payables52,334,946
Average Inventory167,869,044.5
Days Sales Outstanding43
Days Payables Outstanding55
Days of Inventory On Hand193

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.24, and the price to book ratio, 2.24, reflect the market's valuation relative to the company's book value. The price to sales ratio, 4.49, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 20.53, and price to operating cash flows, 19.17, gauge market valuation against cash flow metrics.

Price Book Value Ratio2.24
Price to Book Ratio2.24
Price to Sales Ratio4.49
Price Cash Flow Ratio19.17
Price Earnings to Growth Ratio11.24
Enterprise Value Multiple14.23
Price Fair Value2.24
Price to Operating Cash Flow Ratio19.17
Price to Free Cash Flows Ratio20.53
Price to Tangible Book Ratio2.89
Enterprise Value to Sales6.07
Enterprise Value Over EBITDA17.01
EV to Operating Cash Flow-96.26
Earnings Yield4.43%
Free Cash Flow Yield-1.64%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Youngy Health Co., Ltd. (300247.SZ) on the SHZ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 164.525 in 2024.

What is the ticker symbol of Youngy Health Co., Ltd. stock?

The ticker symbol of Youngy Health Co., Ltd. stock is 300247.SZ.

What is company IPO date?

IPO date of Youngy Health Co., Ltd. is 2011-07-29.

What is company current share price?

Current share price is 2.970 CNY.

What is stock market cap today?

The market cap of stock today is 2387998800.000.

What is PEG ratio in 2024?

The current 11.237 is 11.237 in 2024.

What is the number of employees in 2024?

In 2024 the company has 483.